| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |